Antiphospholipid antibodies

Annals of Neurology
S R Levine, K M Welch

Abstract

Lupus anticoagulants and anticardiolipin antibodies, known collectively as antiphospholipid antibodies, are becoming established as markers for increased risk of thrombosis, including ischemic cerebrovascular disease. In this brief review, we highlight evidence for and against a pathogenetic role of these antibodies in ischemic brain disease and comment on currently available laboratory studies to detect them. Future research on the association of antiphospholipid antibodies with neurological disease should focus on establishing the pathogenicity of these antibodies, identifying groups at high risk for recurrent ischemic cerebrovascular events, and initiating prospective multicenter natural history and treatment protocols.

References

Jan 1, 1989·Annals of the Rheumatic Diseases·E N Harris
Mar 1, 1989·Annals of Neurology·D P BrileyS H Goodnight
Mar 1, 1989·Annals of Neurology·K B DigreJ R Baringer
Jan 1, 1987·Stroke; a Journal of Cerebral Circulation·S R Levine, K M Welch
May 1, 1987·Seminars in Arthritis and Rheumatism·R A AshersonG R Hughes
Jun 1, 1987·Cephalalgia : an International Journal of Headache·S R LevineK M Welch
Jan 22, 1988·JAMA : the Journal of the American Medical Association·D A TriplettC A Orr
Sep 15, 1988·Biochemical and Biophysical Research Communications·T ExnerB Trudinger
May 1, 1988·Ophthalmology·S R LevineK M Welch

❮ Previous
Next ❯

Citations

Jul 1, 1994·Digestive Diseases and Sciences·P ChamouardR Baumann
Sep 8, 1995·Psychiatry Research·H A OomenR J Smeenk
Jun 8, 2002·Survey of Ophthalmology·Omar M DurraniPhilip I Murray
Sep 5, 2001·Neurologic Clinics·D S Higgins
Jul 23, 2008·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·V S FungD S Crimmins
Apr 1, 1995·BMJ : British Medical Journal·C TzourioM G Bousser
Mar 1, 1991·Postgraduate Medical Journal·D W Dunbabin, P A Sandercock
Dec 1, 2004·Kidney International·Hitoshi YokoyamaUNKNOWN Kanazawa Study Group for Renal Diseases and Hypertension
Jan 1, 1992·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·R K Mosewich, A Shuaib
May 13, 1999·The American Journal of Medicine·G Galindo-RodríguezC Lavalle
Nov 1, 1996·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·M W JacobsonG E Tietjen
Jul 1, 1991·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Y MoladN Eynan
Jan 1, 1992·Current Eye Research·A M KlokA Kijlstra
Sep 21, 2000·Cephalalgia : an International Journal of Headache·C TzourioA Alpérovitch
Apr 1, 1992·Cephalalgia : an International Journal of Headache·R Hering
Dec 1, 1994·Stroke; a Journal of Cerebral Circulation·J MontalbánA Gil
Dec 1, 1993·Stroke; a Journal of Cerebral Circulation·T J KilpatrickR J Dauer
Dec 1, 1990·Stroke; a Journal of Cerebral Circulation·P DavousM Samama
Nov 1, 1996·Stroke; a Journal of Cerebral Circulation·R F MackoM Fisher
Sep 1, 1991·Annals of the Rheumatic Diseases·R CaporaliA Martini
Dec 1, 1994·Acta Neurologica Scandinavica·M J FulhamR R Tuck
Oct 8, 1999·Acta Neurologica Scandinavica·M KallelaJ Kaprio
Jun 1, 1992·Arquivos de neuro-psiquiatria·E InamoratoE Zukerman
Jun 15, 1992·Hospital Practice·G M Eisenberg
Mar 8, 2007·Annals of Saudi Medicine·A K DaifA Ogunniyi
Apr 1, 1992·Cephalalgia : an International Journal of Headache·G E Tietjen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

© 2022 Meta ULC. All rights reserved